The American College of Obstetricians & Gynecologists (ACOG) has published new clinical guidance on managing menopause-related vasomotor symptoms (VMS), sleep disturbance, and moo ...
Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC ...
For primary care physicians, the question is increasingly whether continuous glucose data could answer a clinically useful ...
Every clinician can prescribe or refer for PrEP. The faculty outline the education, team structures, and community outreach ...
A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit ...
The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Natera's multi-cancer early ...
Adolescents and young adults with sporadic colorectal cancer (CRC) most often present with stage III or IV disease, and only ...
Pauline M. Maki, PhD, introduces OPTION-VMS and explains why real-world data are needed to test whether randomized trial ...
Freenome reports 18.2% sensitivity for advanced precancerous lesions and 80.4% for colorectal cancer with its updated blood ...
Pauline M. Maki, PhD, reviews the first data cuts from OPTION-VMS, released at The Menopause Society 2025 meeting. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results